Copanlisib Pharmacodynamic Study

Clinical trial NCT02155582 · COMPLETED

Trial details

NCT number: NCT02155582
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non Hodgkin Lymphoma

Start date: 2014-08-12
Primary completion: 2016-10-04
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.